These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6389484)

  • 21. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
    Dockhorn RJ; Cefali EA; Straughn AB
    Ann Allergy; 1994 Mar; 72(3):218-22. PubMed ID: 8129214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability of four slow-release theophylline formulations in the beagle dog.
    Koritz GD; McKiernan BC; Neff-Davis CA; Munsiff IJ
    J Vet Pharmacol Ther; 1986 Sep; 9(3):293-302. PubMed ID: 3761420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
    Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
    Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence of a generic slow-release theophylline tablet in children.
    Kanthawatana S; Ahrens RC; McCubbin M; Bronsky E; Blake K; Hendeles L
    J Pediatr; 1994 Dec; 125(6 Pt 1):987-91. PubMed ID: 7996375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion from intravenous to sustained-release oral theophylline in pediatric patients with asthma.
    Clarke DF; Werbowsky OL; Grodin MA; Shargel L
    Drug Intell Clin Pharm; 1986 Sep; 20(9):700-3. PubMed ID: 3757784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of circadian variation of serum theophylline concentration and bioavailability between Theo-dur tablet and a new sustained-release theophylline formulation (E-0686 granule)].
    Kishida M; Okuma M; Uekusa T; Akimoto K; Obata T; Akazawa A; Odajima Y; Nagakura T; Iikura Y; Hukushima K
    Arerugi; 1988 Apr; 37(4):218-25. PubMed ID: 3228360
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theophylline levels and clinical response in asthmatic adults receiving long-term Uniphyl.
    Petty TL; Rollins DL
    Am J Med; 1985 Dec; 79(6A):73-6. PubMed ID: 2867679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
    Menendez R; Kelly HW; Howick J; McWilliams BC
    Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enprofylline and theophylline slow-eroding tablets in the treatment of asthma: a comparison.
    Laursen LC; Eriksson G; Weeke B
    Respiration; 1986; 50(1):57-61. PubMed ID: 3523664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained-release theophylline for treatment of asthma in preschool children.
    Simons FE; Luciuk GH; Simons KJ
    Am J Dis Child; 1982 Sep; 136(9):790-3. PubMed ID: 7114002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
    Rojanasthien N; Kovjiriyapan K; Manorot M; Pothirat C
    Asian Pac J Allergy Immunol; 2001 Jun; 19(2):69-78. PubMed ID: 11699723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur Sprinkle.
    Karim A; Burns T; Wearley L; Streicher J; Palmer M
    Clin Pharmacol Ther; 1985 Jul; 38(1):77-83. PubMed ID: 4006379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison study of sustained-release theophylline products: Slo-bid capsules versus Theo-Dur tablets in 20 children and young adults with asthma.
    Hannaway PJ; Hopper GD
    J Allergy Clin Immunol; 1986 Mar; 77(3):456-64. PubMed ID: 3512663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and clinical response to single- and multiple-dose sustained-release theophylline compounds in perennial bronchial asthma.
    Fanta CH; McFadden ER
    Am J Med; 1985 Dec; 79(6A):54-7. PubMed ID: 4083300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a sustained-release preparation (Theo-Dur) with a conventional preparation (Nuelin) in the treatment of chronic asthma.
    Haahtela T; Vilkka V; Kulstad S
    Allergy; 1983 Nov; 38(8):589-92. PubMed ID: 6660438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption characteristics of once-a-day slow-release theophylline preparation in children with asthma.
    Pedersen S; Steffensen G
    J Pediatr; 1987 Jun; 110(6):953-9. PubMed ID: 3585612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of the North American experience with evening administration of Uniphyl tablets, a once-daily theophylline preparation, in the treatment of nocturnal asthma.
    Arkinstall WW
    Am J Med; 1988 Jul; 85(1B):60-3. PubMed ID: 3400688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.